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Bmp, Fgf, and retinoic acid (RA) signals have been implicated as regulators of pancreas development. However, the integration of these signaling
pathways in vivo is not fully understood. Variant hnf1 (Vhnf1) is a transcription factor involved in pancreas, liver, and kidney development and its
mutation in zebrafish causes underdeveloped pancreas and liver. We investigated the signaling pathways that regulate vhnf1 expression during
pancreas development. First, we showed that Bmp activity is required for vhnf1 expression in the endoderm. In chordin (a Bmp antagonist)
morpholino (MO)-injected embryos, vhnf1 expression in endoderm and in endocrine β cells is expanded. On the other hand, in alk8 (a type I TGFβ
receptor) MO-injected embryos, vhnf1 expression in the endoderm is significantly reduced. Second, we showed that Fgf signaling participates in
regulation of pancreas development through the vhnf1 pathway. Third, we demonstrated that RA fails to rescue reduction of insulin expression in
vhnf1 mutants, whereas overexpression of vhnf1 restores insulin expression that is repressed by treatment with a RA receptor inhibitor. And
finally, we revealed that both Bmp and Fgf signals act genetically upstream of RA in directing pancreas development. Taken together, our data
establish that vhnf1 acts downstream of the signaling pathways of RA, Bmp, and Fgf to regulate pancreas development in zebrafish.
© 2006 Published by Elsevier Inc.Keywords: Zebrafish; Pancreas development; Fgf; RA; Bmp; vhnf1Introduction
The pancreas is a compound gland that functions in both the
endocrine and the digestive systems. The endocrine cells of
pancreas secrete peptide hormones directly into the bloodstream
to maintain glucose homeostasis. Failure of the insulin-
producing β cells to function properly results in diabetes.
Thus it is important to understand the molecular mechanisms
underlying pancreas development, especially β cell specifica-
tion. Development of the pancreas is a dynamic process that
requires extrinsic signals to provide positional information and
a network of transcription factors to interpret these signals and
specify pancreatic fate. Although extrinsic signals and tran-
scription factors have been identified from different model
organisms, including mice and zebrafish, the mechanisms of
signal interpretation and integration are not fully understood. In
this study, we investigate how transcription factors respond to⁎ Corresponding author. Fax: +1 310 267 4971.
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0012-1606/$ - see front matter © 2006 Published by Elsevier Inc.
doi:10.1016/j.ydbio.2006.11.040and integrate positional signals to direct pancreas development,
using the zebrafish variant hepatic factor 1 (vhnf1, also known
as hnf1β) gene as an entry point.
Many of the extrinsic signaling pathways directing pancreas
development appear to be conserved between zebrafish and
other vertebrates. In zebrafish, the dorsoventral (DV) patterning
signals appear to be involved in endodermal precursor pre-
patterning. Tiso et al. (2002) has reported that a gradient of Bmp
activity is involved in endoderm patterning in zebrafish. They
showed that the Bmp gradient does not disturb the induction of
endodermal precursors using markers such as cas and sox17.
However, the Bmp gradient remarkably affects the expression
domain of the regionalized endodermal marker her5. Increase of
Bmp activity caused remarkable reduction of her5 expression
domain. On the other hand, decrease of Bmp activity leads to the
expansion of her5 expression domain. Therefore, a balanced
Bmp gradient seems important for endoderm patterning in
zebrafish. Tiso et al. (2002) further demonstrated that Bmp
activity also plays an important role in the differentiation and
positioning of endodermal derivatives. In swirl/bmp2b mutants,
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and islet-1, two early pancreatic markers, is dramatically
reduced. In contrast, the islet-1 expression domain is slightly
enlarged in chordino mutants (in which the embryos are
ventralized). Interestingly, increase of Bmp signaling in chor-
dino mutants also affects the left–right positioning of pancreas
and liver. This result suggests that the dorsoventral Bmp
signaling is required for proper pancreas development in
zebrafish.
Fgf signals are essential for normal development of pancrea-
tic islets. In chick, Fgf2 is identified as a notochord factor that
represses sonic hedgehog (SHH) expression in adjacent nascent
pancreatic endoderm, which in turn permits the expression of
pancreatic genes such as Pdx-1 and insulin (Hebrok et al.,
1998). In addition, Fgf signaling may have a role in
differentiated β cells. Both Fgfs (Arany and Hill, 2000; Hart
et al., 2000; Ishiwata et al., 1998a,b) and Fgf receptors (FGFRs)
(Hart et al., 2000; Hughes, 1997; Ishiwata et al., 1998a; Kim et
al., 2001; Oberg-Welsh and Welsh, 1996) are expressed in
pancreatic islets. Transgenic mice carrying a dominant-negative
form of FGFR1c under the control of a pdx-1 promoter,
developed diabetes with age and showed a decreased number of
β cells (Hart et al., 2000). In zebrafish, a recent study suggests
that Fgf8 and Fgf3 play essential roles in regulating segmenta-
tion of the pharyngeal endoderm into pouches in zebrafish
embryo (Crump et al., 2004), indicating that Fgf signals are
required for endoderm patterning. However, its role in zebrafish
pancreas development has not been fully addressed.
Retinoic acid (RA) signaling is essential for endodermal
patterning and has a conserved role in vertebrate pancreas
development. In Xenopus laevis and quail, RA signaling is
required for pancreas development but not for liver develop-
ment. In X. laevis, RA signal promotes endocrine cell fate at the
expense of exocrine differentiation in the dorsal pancreas,
whereas it enhances exocrine marker gene expression in the
ventral pancreas (Chen et al., 2004). In zebrafish, treatment of
embryos at 9–10 hpf with 10−6 M RA for 1 h causes minimal
alterations in morphology but dramatic anterior ectopic
expression of all pancreatic markers including insulin, soma-
tostatin, and glucagon. On the other hand, the expression of
these endocrine markers and trypsin (as exocrine cell marker)
was undetectable in embryos treated with reagent BMS493, a
pan-RA receptor antagonist (Stafford and Prince, 2002). This
result indicates that RA is necessary for differentiation of both
endocrine and exocrine cells of the pancreas.
Together, these data suggest that signaling pathways
including Fgf, Bmp, and RA are required for pancreas
development. However, the relationship and integration of
these signals by the pancreatic precursors in vivo to initiate the
transcription factor program governing pancreas development
remain poorly understood.
During a previous ENU mutagenesis screen for mutations
affecting early endocrine pancreas development, we isolated the
mislet (msl) mutant that showed severely reduced insulin
expression at 24 hpf and absent liver and exocrine pancreas
marker expression at 3 day post-fertilization (dpf) (Kim et al.,
2006). We found that msl is an allele of the vhnf1 gene. Inzebrafish, vhnf1 mutants exhibit underdeveloped liver and
pancreas and is required for the expression of pancreatic
duodenal homeobox 1 (Pdx-1) in the gut endoderm (Sun and
Hopkins, 2001). Pdx-1 is one of the most important transcription
factors in regulating pancreas development (Jonsson et al.,
1994). In zebrafish, injection of a pdx-1 morpholino disrupted
both pancreas development and expression of insulin, glucagon,
and somatostatin (Yee et al., 2001). These data suggest that
vhnf1, likely acts through Pdx-1, is required for early stages of
pancreas specification. In a separate study, it was shown that that
Vhnf1 is a downstream mediator of retinoic acid signaling in the
zebrafish hindbrain patterning (Hernandez et al., 2004),
implying a similar mechanism in pancreas development.
In this study, we demonstrated that Bmp activity is required
for endocrine pancreas development in zebrafish. Vhnf1
mediates the regulation of pancreas development by Bmp
activity. Furthermore, the Bmp signal acts upstream of the RA
pathway to direct pancreas development. We also showed that
Fgf signals are essential for zebrafish endocrine pancreas
development. Vhnf1 is able to rescue the endocrine pancreas
defects in embryos with reduced Fgf. Finally, Fgf signaling
depends on RA for the regulation of vhnf1 expression and
pancreas development. Taken together, we find that Vhnf1 is
required by signals from Fgf, Bmp, and RA to regulate pancreas
development in zebrafish.
Materials and methods
Fish maintenance
Zebrafish were raised and kept under standard laboratory conditions at about
28 °C. The msl mutation (a point mutation in vhnf1 gene) was identified in a
previous ENU screen (Kim et al., 2006). vhnf1hi2169 was a gift from Hopkins'
laboratory at MIT (Sun and Hopkins, 2001). The wild-type line used was AB.
In situ hybridization
In situ hybridization was performed as described (Hauptmann and Gerster,
2000; Jowett, 1999). Following probes were used: vhnf1 (Sun and Hopkins,
2001), foxa3, and insulin (Milewski et al., 1998).
Chemical treatment
For retinoic acid treatment, wild-type zebrafish embryos were incubated
with retinoic acid as described (Stafford and Prince, 2002). For diethylamino-
benzaldehyde (DEAB) treatment, embryos were incubated with 10−5 M or
10−6 M DEAB diluted from 10−2 M stock solution in DMSO as described
(Begemann et al., 2004).
RNA synthesis and injection
fgf3, fgf8, and vhnf1 mRNAs were synthesized using T7 or SP6 mMessage
mMachine kit (Ambion). mRNA injection was performed as described at the
one-cell stage (Hyatt and Ekker, 1999). Sterile water was used for the control
experiments. 50 pg of vhnf1 mRNAwas used for all experiments. fgf3 and fgf8
mRNAs were mixed in 1:1 ration and injected at 100 pg per embryo.
Injection of morpholino oligonucleotides
Antisense morpholino oligos (MOs) designed against fgf3 (CATTGTGG-
CATGGAGGGATGTCGGC), fgf8 (GAGTCTCATGTTTATAGCCTCAGTA),
Fig. 1. Bmp activity regulates vhnf1 expression in the developing pancreatic
endoderm. vhnf1 in situ hybridization patterns at 26 hpf in (A) embryo injected
with 1 ng of standard control oligo. (B) Embryo injected with 1 ng of alk8
morpholino. (C and D) Two examples of embryos injected with 1 ng of chordin
morpholino. White arrows indicate endoderm. All samples are dorsal view with
anterior to the left. Scale bar: 200 μm.
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CAGCCCCTCCATCATCC) were obtained from Open Biosystems and injected
into one- to two-cell stage embryos. All morpholinos were prepared and
resuspended in 1× Danieau's buffer at ∼0.4 ng/nl for injection. Since specific
activities of these morpholinos have been previously reported we only used the
standard random MO oligos as negative control for injections. alk8 and chordin
morpholino were injected at 1 ng per embryo respectively for all experiments.
Fgf3 and fgf8 morpholino were injected at 2 ng per embryo respectively. Fgf3/
8 morpholinos were mixed in 1:1 ratio and injected at 3 ng or 2 ng per embryo.
Imaging and quantification
Images were captured using a digital camera (Axiocam) attached to a
compound microscope (Zeiss: axioplan 2) and an Openlab program (Improvi-
sion). Confocal images and time laps images were captured using a Zeiss LSM
510 Laser Scanning Confocal Microscope. To quantify insulin-positive cell
numbers, yolk was removed from the embryo and the rest of the embryo was
flattened by cover slide. GFP-positive cells were counted under a compound
microscope.
Results
Bmp activity regulates vhnf1 expression in the developing
endoderm
It has been reported that a balanced Bmp2b signaling is
required for normal zebrafish pancreas development. Decrease
of Bmp2b activity resulted in a dramatic reduction of pancreatic
primordium, whereas increase of Bmp2b activity by inhibiting
Chordin caused its expansion (Tiso et al., 2002).
In our previous genetic screen for genes involved in pancreas
development, msl was identified (Kim et al., 2006) and
characterized as an allele of vhnf1 (see Supplementary online
data). The msl mutant carries a point mutation within the
homeobox domain that abolishes the DNA-binding ability.
Zebrafish carrying the mutant allele vhnf1hi2169 was crossed to
msl mutants. The resulting double-heterozygous mutants
showed severely reduced insulin expression in the developing
pancreatic area (data not shown).
Due to the similarity of defects in insulin expression in vhnf1
mutants and in embryos with decreased Bmp activity, we
investigated whether Bmp activity is required for vhnf1
expression in the developing endoderm. The vhnf1 gene is
dynamically expressed during embryogenesis. Expression
begins in the presumptive foregut endoderm from the early
pharyngula stage. Weak expression in the hindgut can also be
detected by in situ hybridization at this stage (Gong et al., 2004;
Sun and Hopkins, 2001). To investigate whether Bmp activity
affects vhnf1 expression in the developing foregut endoderm, we
injected antisense morpholino oligonucleotides against alk8
mRNA and chordin mRNA into zebrafish embryos at one- to
two-cell stages. The alk8 gene encodes a type I transforming
growth factor beta (TGFβ) receptor. Inactivation of alk8 gene
blocks the transduction of Bmp signals (Bauer et al., 2001;
Mintzer et al., 2001; Payne et al., 2001). In situ hybridization
with a vhnf1 probe was performed at 26 hpf. In control oligo-
injected embryos, vhnf1was expressed in the developing foregut
endoderm as well as pronephric tubules (Fig. 1A). This
expression pattern was affected by Bmp activity. The foregut
endoderm expression was remarkably reduced in the alk8morpholino-injected embryos (Fig. 1B, white arrows), whereas
the expression in the pronephric tubules appeared normal. In
contrast, when Bmp activity was increased by reducing its
antagonist Chordin, vhnf1 expression in the developing foregut
endoderm seems slightly increased and expanded anteriorly,
whereas vhnf1 expression appeared normal in the pronephric
tubules (Figs. 1C, D). These results indicate that Bmp activity is
required specifically for vhnf1 expression in the developing
endoderm.
Vhnf1 rescues reduction of insulin expression in Bmp-deficient
embryos
To investigate whether Vhnf1 is required for Bmp regulation
of pancreas development, vhnf1 mRNA was injected into
embryos at one-cell stage followed by alk8morpholino injection
at two- to four-cell stage. Injection of vhnf1 mRNA into wild-
type embryos slightly increases insulin expression in the
developing pancreatic area (Fig. 2C). More interestingly,
injection of vhnf1mRNA restored insulin expression in embryos
injected with alk8morpholino (Fig. 2D) to a level comparable to
control embryos (Fig. 2A). In a complementary experiment, we
injected chordin morpholino into embryos homozygous for the
vhnf1hi2169 allele. Uninjected vhnf1hi2169 homozygous mutants
showed severely reduced insulin expression at 24 hpf (Fig. 2G).
Although injection of the chordin morpholino resulted in an
increase of Bmp activity, it was not enough to rescue insulin
expression in vhnf1hi2169 mutant embryos (Fig. 2H). Using a
transgenic fish carrying insulin:GFP, we reconstructed 3D
confocal images of insulin-positive cells (Figs. 2I–L). We
further quantified the insulin-positive cell numbers in our
experimental groups. In our control group, the average insulin-
positive cell number is 17.48±1.63 per embryo (n=78, Table
S1). Increase of Bmp2 activity by chordin morpholino injection
resulted in slight increase of insulin cell number (20.12±1.29
cells per embryo, N=71, Table S1). Conversely, decrease of
Bmp activity in alk8 morphants caused significant reduction of
insulin cell numbers (4.77±1.71 cells per embryo, N=86, Table
S1). Furthermore, injection of vhnf1 mRNA to alk8 morphants
Fig. 2. Bmp signal regulates pancreas development through Vhnf1. (A–H) In situ hybridization with an insulin probe at 24 hpf. (A) Control embryo injected with 5 nl
of water. (B) 1 ng of alk8morpholino-injected embryo. (C) Embryo injected with 50 pg of vhnf1mRNA. (D) Embryo injected with 50 pg of vhnf1mRNA followed by
1 ng of alk8 morpholino injection. (E) Control embryo injected with 1 ng of standard control oligo. (F) Embryo injected with 1 ng of chordin morpholino. (G)
vhnf1hi2169 homozygotic embryo. (H) 1 ng of chordin morpholino-injected embryo in vhnf1hi2169 homozygotic background. All samples are dorsal view with anterior
to the left. Yolk was partially removed from embryos. Scale bar: 50 μm. (I–L) Confocal 3D reconstruction of insulin:GFP-positive cells at 24 hpf. (I) Control embryo.
(J) chordin morpholino (1 ng)-injected embryo. (K) alk8 morpholino (1 ng)-injected embryo. (L) Embryo injected with 50 pg of vhnf1 mRNA followed by 1 ng of
alk8 morpholino injection. (M) 14-somite stage control embryo. (N) chordin morpholino (1 ng)-injected embryo at 14 somites. (O) alk8 morpholino (1 ng)-injected
embryo at 14 somites. (P) 14-somite embryo injected with 50 pg of vhnf1 mRNA followed by 1 ng of alk8 morpholino injection. Scale bar: 50 μm. (Q–S) In situ
hybridization using a foxa3 probe at 31 hpf. Dorsal view, anterior to the left. L–R meaning left–right axis. (Q) Control embryo. Note both liver (arrow) and pancreas
(arrowhead) are formed at the correct positions. (R) Embryo injected with 1 ng of alk8morpholino. Note no live or pancreas formed at the corresponding positions. (S)
Embryo injected with 50 pg of vhnf1 mRNA followed by 1 ng of alk8morpholino. Note both liver (arrow) and pancreas (arrowhead) are formed at the right locations.
(T) Statistic graph for insulin-expressing cell numbers. Y-axis, percentage of insulin-expressing cell number compared to control. X-axis, experimental groups.
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(12.64±1.70 cells per embryo) in about 70% of the embryos
(N=72). This result implies that vhnf1 is required for Bmp
modulation of pancreas development. Taken together, our results
suggest that Bmp signals act upstream of Vhnf1 in modulating
pancreas development in zebrafish.To investigate the timing of Vhnf1 action in endocrine
pancreas development, we traced back of GFP cells in our
experimental groups to 12-somite and 14- to 15-somite stages.
At 12-somite stage, only a few cells (usually around five) start
to express GFP at extremely low level in our control group (data
not shown). No GFP-positive cells are observed in alk8
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average GFP-positive cell number is 7±3 in our control group
(N=22, Fig. 2M). Increase of Bmp activity by chordin
morpholino slightly increased the cell number to 8±3 (N=20,
Fig. 2N). Conversely, decrease of Bmp signaling by alk8
morpholino dramatically reduced the GFP cell number to 3±3
at 14- to 15-somite stage (N=19, Fig. 2O). Interestingly,
injection of vhnf1 mRNA to alk8 morphants successfully
brought GFP cell number up to 5±2 (N=20, Fig. 2P). This
result suggests that Vhnf1 acts at very early stage when the
progenitor cells begin the commitment to β cell fate.
Vhnf1 mutants exhibit underdeveloped liver in addition to
pancreas and kidney defects (Sun and Hopkins, 2001). To
determine whether rescue by vhnf1 mRNA in alk8 morphants is
limited to pancreas, in situ hybridization was performed using a
foxa3 probe. Foxa3 is a forkhead-related gene that is expressed
in the endoderm as well as the neural crest and axial mesoderm
(Odenthal and Nusslein-Volhard, 1998). At about 31 hpf, foxa3
is expressed in liver (arrow), pancreas (arrowhead) and gut in
the wild-type control embryo (Fig. 2Q, N=56). Decrease of
Bmp activity by alk8 morpholino injection caused a change of
foxa3 expression pattern. No liver or pancreas bud is observed
in the alk8 morphants (Fig. 2R, N=78). Interestingly, injection
of vhnf1 mRNA into alk8 morphants can rescue both liver and
pancreas expression of foxa3 (Fig. 2S, N=66).
Fgf signals are required for endocrine pancreas development
To investigate whether Fgf signals are required for endocrine
pancreas development in zebrafish, we applied fgf morpholino
oligonucleotides to insulin:GFP transgenic embryos at the one-
to two-cell stage. Compared to standard control oligo-injectedFig. 3. Fgf signals are required for pancreas development. Insulin:GFP transgenic emb
morpholino (J), 2 ng of fgf8morpholino (K), or 3 ng (total amount in 1:1 ratio) of fgf3
Note GFP spots are reduced and placed randomly in panels (B–D). (B) An example
positioned at left side pancreas. (D) An example of reduced and positioned at right s
high magnification. (F) fgf3/8 morphant with five GFP cells. (G) fgf3/8 morphant wit
are confirmed by insulin in situ hybridization in panels (I–L). (I) Embryo injected wit
injected with fgf8morpholino. (L) Embryo injected with fgf3 and fgf8morpholinos. D
All embryos were at 24 hpf. Scale bar: 50 μm.embryos (Figs. 3A and E), insulin promoter-driven GFP
expression at 24 hpf stage was dramatically reduced in the
developing pancreatic area in fgf3/8 morpholino-injected
embryos (Figs. 3B–D and F–H). In addition, decrease of Fgf
signaling resulted in randomization of insulin:GFP cells in
about 40% of the affected embryos (N=144) (Fig. 3C) in term
of left–right axis. Reduction in GFP expression suggests
underdeveloped pancreas in these embryos. This result was
confirmed by in situ hybridization with an insulin probe.
Compared to standard control oligo-injected embryos (Fig. 3I),
insulin expression was remarkably reduced in fgf3 morpholino-
injected embryos (Fig. 3J) and fgf8 morpholino-injected
embryos (Fig. 3K). Double injection of fgf3 and fgf8
morpholinos seemed to result in further reduction of insulin
expression (Fig. 3L). These data imply that Fgf signals are
necessary for pancreas development.
Vhnf-1 can rescue insulin expression caused by Fgf defects
We have shown that Vhnf1 is required for Bmp function in
pancreas development. To investigate whether Vhnf1 is also
required for Fgf function in pancreas development, we injected
insulin:GFP transgenic embryos with vhnf1mRNA followed by
injection of Fgf morpholinos. Injection of vhnf1 mRNA alone
resulted in slightly increased GFP expression (Figs. 4A–C).
Compared to fgf3 and fgf8 morpholino-injected embryos (Figs.
4G–I), overexpression of vhnf1 mRNA restored GFP expres-
sion in Fgf-deficient embryos to the level comparable to control
embryos (Figs. 4D–F). Quantification data indicate that Vhnf1
is able to restore insulin-positive cell number to 63.9% of the
control level in 73% of the embryos (N=106, Table S2). This
result suggests that Vhnf1 is required for Fgf function inryos were injected with 2 ng of a standard control oligo (A, E and I), 2 ng of fgf3
/8morpholinos (B–D, F–H, and L). (A–D) Low magnification of confocal view.
of reduced and normally positioned pancreas. (C) An example of reduced and
ide pancreas. (E–H) 3D confocal reconstruction of insulin:GFP-positive cells at
h six GFP cells. (H) fgf3/8 morphant with two GFP cells. The pancreatic defects
h standard control oligo. (J) Embryo injected with fgf3 morpholino. (K) Embryo
orsal view, anterior to the left. Yolk was partially removed from in situ embryos.
Fig. 4. Vhnf1 acts downstream of Fgf signaling in early pancreas development: injection of vhnf1 mRNA rescued fgf morpholino defects in endocrine pancreas
development. (A–C) Embryo injected with 50 pg vhnf1mRNA. (D–F) Embryo injected with 50 pg vhnf1mRNA followed by 3 ng of fgf3/8 (1:1) morpholinos. (G–I)
Embryo injected with 3 ng of fgf3/8morpholinos as control. (A, D, and G) Lateral view, anterior to the left. (B, E, and H) Dorsal view. Anterior to the left. (C, F, and I)
Higher magnification showing GFP-positive β cells. Scale bars: 200 μm for lower magnification, 50 μm for higher magnification (C, F, and I). All embryos were at
24 hpf. (J) Time laps 3D confocal reconstruction of insulin:GFP cells at different developmental stages for control embryo (upper panel), fgf3/8 (3 ng) morphant
(middle panel), and fgf3/8 (3 ng) morphant with 50 pg of vhnf1 mRNA injection (lower panel). Arrows point to newly differentiated β cells with low level of GFP
expression. Note the early differentiated β cells with saturated GFP intensity at the same scanning condition (arrowheads). Scale bar: 50 μm.
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Fgf signals. However, it is possible that there is vhnf1-
independent Fgf function in pancreas development since
vhnf1 is only able to partially restore β cell number in fgf
morphants.
In mouse, hnf1β expression begins at early bud stage during
pancreas development (Servitja and Ferrer, 2004). Similarly,
zebrafish vhnf1 gene also starts to express at very early stage of
pancreas development (Fig. 12). Therefore, we hypothesized
that Vhnf1 is required at very early stage during β cell
specification. We tested this hypothesis using insulin:GFP
transgenic fish to take time laps confocal images. The start time
points were 12-somite stage and marked as 0 h. Injection of fgfmorpholinos caused about 3 h of developmental delay. In the
control embryos injected with standard control morpholino,
insulin:GFP expression begins weakly in a few cells (about six)
at 12-somite stage (Fig. 4J upper panel), and becomes more
obvious in more cells (around 14 cells) at 14-somite stage (Fig.
4J upper panel). Note late differentiated β cells with low
intensity of GFP at this stage (Fig. 4J upper panel, arrow). At
18-somite and 22-somite stages, the early differentiated β cells
exhibit saturated GFP intensity (Fig. 4J upper panel, arrow-
head), and more cells appear to express high level of GFP. In the
differentiated β cells, GFP expression becomes more intense as
the embryo grows. These GFP cells form a cluster at 24 hpf
(Fig. 4J upper panel). Usually, there are about seventeen GFP
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signaling caused much less cells (1 or 2 cells per embryo,
N=20) expressing GFP at low level at 14-somite stage. In most
cases, no GFP-positive cells are observed at 12-somite stage
(Fig. 4J middle panel). As the embryo grows, GFP-positive cell
number only slightly increases although they also form a small
cluster at 24 hpf (Fig. 4J middle panel). In this particular case,
there are seven β cells at around 24 hpf. The average β cell
number in fgf3/8 morphants is 3 (Table S2). In addition to cell
number, the GFP cell size in fgf morphants appears smaller than
that in control. Interestingly, injection of vhnf1 mRNA to fgf
morphants successfully restored GFP expression as early as 12-
somite and more at 18-somite stage (5 or 6 cells per embryo,
N=20) (Fig. 4J lower panel, 14 somites). This result suggests
that vhnf1 acts as one of the earliest genes in the precursor cells
that were determined to develop into β cells.
In the complimentary experiment, we examined whether Fgf
signal could rescue β cell development in the vhnf1 mutant.
Injection of fgf3/8 mRNA slightly increases β cell number in
wild-type embryo (Fig. 5E). When fgf3/8 mRNA was injected
into embryos collected from vhnf1 mutant background, about
28% of the embryos (N=108) exhibit significantly reduced
insulin expression similar to uninjected vhnf1−/− control. The
β cell number remains in similar level to control (Fig. 5I). This
result provides further evidence that vhnf1 functions down-
stream of Fgf signals in β cell development. We further
analyzed the endoderm development in fgf morphant using a
foxa3 probe. In the wild-type control embryo, foxa3 is
expressed in liver, pancreas and gut (Fig. 5A). fgf3/8morpholinoFig. 5. Fgf signals cannot rescue the msl β cell development. (A–D) In situ hybridiza
(3 ng)-injected embryo, (C) vhnf1 mRNA (50 pg)-injected embryo, (D) vhnf1 mRNA
indicate liver and pancreas respectively. Note underdeveloped liver and pancreas are
24 hpf. (E) Wild-type control embryo, (F) fgf3/8 mRNA (100 pg)-injected embryo,
Scale bar: 50 μM. (I) Quantification of insulin-expressing cell number. The percentag
control embryos. Column 2, fgf3/8 mRNA-injected embryos. Column 3, vhnf1−/− einjection caused underdeveloped liver and pancreas (Fig. 5B,
N=80). But gut appears normal in fgf3/8 morphant. Over-
expression of vhnf1 gene did not cause noticeable change of
foxa3 expression in wild-type embryo (Fig. 5C, N=50).
However, injection of vhnf1 mRNA into fgf3/8 morphant
successfully rescued liver and pancreas expression of foxa3
(Fig. 5D, N=69).
Retinoic acid (RA) treatment cannot rescue reduction of insulin
expression in vhnf1 mutants
So far, homozygous mutations in two genes, retinaldehyde
dehydrogenase-2 (raldh2, neckelss) (Stafford and Prince, 2002)
and vhnf1 (both the vhnf1hi2169 insertional allele and the msl
point mutation), have been reported to result in reduced insulin
expression at 24 hpf and absent exocrine pancreas and liver at 3
dpf. We tested whether treating msl mutant embryos with
retinoic acid can rescue the reduction of insulin expression at
24 hpf. We treated the progeny of msl carriers with 4×10−6 M
of RA at 9 hpf for 1 h, and assayed for insulin expression at
24 hpf by in situ hybridization with an insulin probe. Retinoic
acid treatment of wild-type embryos resulted in expanded in-
sulin expression as previously described (Fig. 6C) (Stafford and
Prince, 2002). The average insulin cell number in this group is
43.96±4.60 (N=50). However, retinoic acid treatment of vhnf1
mutant embryos (Fig. 6D) did not cause significantly difference
of insulin expression compared to vhnf1 mutants (Fig. 6B). In
both groups, the average insulin cell number is still 2±2
(N=40). Interestingly, over 30% of the progeny of msl carrierstion using a foxa3 probe at 31 hpf. (A) Wild-type embryo, (B) fgf3/8morpholino
(50 pg) and fgf3/8 morpholino (3 ng)-injected embryo. Arrows and arrowheads
a in fgf3/8 morphant (B). (E–H) In situ hybridization using an insulin probe at
(G), vhnf1−/− embryo, (H) fgf3/8 mRNA (100 pg) injected vhnf1−/− embryo.
e of insulin-expressing cells to wild-type control is shown. Column 1, wild-type
mbryos. Column 4, fgf3/8 mRNA-injected vhnf1−/− embryos.
Fig. 6. RA treatment cannot rescue the msl mutant phenotype. (A–D) In situ hybridization with an insulin probe at 24 hpf. (A) DMSO-treated wild-type embryo, (B)
DMSO-treated mslmutant embryo, (C) RA-treated (10−6 M) wild-type embryo, notice that the number of insulin cells increased significantly compared to the DMSO-
treated embryo, (D) RA (10−6 M)-treatedmslmutant embryo, notice that the RA treatment did not increase insulin expression significantly. Dorsal view, anterior to the
left. Scale bar: 50 μm. (E) Quantification of embryos treated with DMSO or RA. All wild-type embryos treated with DMSO have normal insulin expression. In
contrast, all wild-type embryos treated with RA show expanded insulin expression. All vhnf1−/− embryos still exhibit reduced insulin expression no matter treated
with either DMSO or RA, indicating that RA treatment cannot rescue vhnf1−/− pancreas phenotype. *Indicates that embryos with mixed genotypes including WT,
vhnf1+/−, and vhnf1−/−.
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expected to be vhnf1 homozygotes (Fig. 6E). A possible
explanation is that the vhnf1 point mutation may partially act in
dominant negative fashion. Our data suggest that RA treatment
cannot rescue the msl mutant phenotype. Therefore, it is likely
that Vhnf1 acts downstream of RA signaling.
Vhnf1 can rescue the absence of insulin expression in RA-
deficient embryos
To test if Vhnf1 can function genetically downstream of RA
signaling pathway, we applied DEAB, a retinoic acid receptor
inhibitor, to POMC (proopiomelanocortin):GFP, insulin:GFP
double transgenic fish. Treatment of DEAB caused the absenceof insulin promoter-driven GFP, but POMC GFP appeared
normal (Fig. 7B) compared with the control (Fig. 7A). Insulin
promoter-driven GFP remained in only 55% of embryos treated
with 1×10−6 M of DEAB (Fig. 7J). No embryo exhibited
insulin-driven GFP when treated with 1×10−5 M of DEAB
(data not shown). Conversely, double transgenic embryos
injected with vhnf1 mRNA followed by treatment with DEAB
had severe morphological defects, but approximately 87% of
the embryos showed insulin promoter-driven GFP expression
(Figs. 7D, E, J). Injection of vhnf1 mRNA alone into double
transgenic zebrafish embryos caused no observable change in
morphology and slight increase of insulin promoter-driven GFP
expression (Fig. 7C). These results were confirmed by
subsequent in situ hybridization with an insulin probe (Figs.
Fig. 7. Vhnf1 can rescue reduced insulin and foxa3 expression in DEAB-treated embryos. (A–E) POMC:GFP, insulin:GFP double transgenic zebrafish embryos,
24 hpf, lateral view, anterior to the left. (F–I) Insulin in situ hybridization, 24 hpf, dorsal view. (A, F) DMSO-treated embryos. (B, G) DEAB (10−6 M)-treated
embryos. (C, H) 50 pg of vhnf1 mRNA-injected and DMSO-treated embryos. (D, E, I) 50 pg of vhnf1 mRNA-injected and 10−6 M of DEAB-treated embryos
display GFP expression in insulin-positive cells despite severe morphological abnormalities. Scale bar: 200 μm for (A–E), 50 μm for (F–I). (J–K) In situ
hybridization with a foxa3 probe at 31 hpf. Dorsal view, anterior to the left. (J) Control embryo. Note the liver (arrow) and pancreas (arrowhead) at the left and right
side of gut respectively. (K) Wild-type embryo treated with 10−6 M of DEAB. Note that no liver or pancreas bud was at the corresponding positions. (L) Embryo
injected with 50 pg of vhnf1 mRNA followed by 10−6 M DEAB treatment. Note that both liver (arrow) and pancreas (arrowhead) are formed at the right locations.
(M) Percentage of embryos that exhibited insulin or no insulin expression. Almost 100% of DMSO-treated embryos maintained a normal GFP pattern. Only 55% of
embryos treated with 1×10−6 M of DEAB had insulin expression. Injection of vhnf1 mRNA followed by 1×10−6 M of DEAB treatment resulted in more than 80%
of embryos with insulin expression.
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retinoic acid signaling in endocrine pancreas formation.
To determine whether vhnf1 mRNA can also rescue liver
development in RA-deficient embryo, in situ hybridization
using a foxa3 probe was performed at around 31 hpf. In wild-
type embryo, foxa3 is expressed in the gut, liver and pancreas.
Treatment of 10−6 M DEAB completely abolished liver and
pancreas foxa3 expression (Fig. 7K, N=105). It appears that
foregut expression of foxa3 is also reduced. However, injectionof vhnf1 mRNA successfully rescued liver and pancreas foxa3
expression (Fig. 7L, N=93). Therefore, vhnf1 can rescue both
liver and pancreas in RA-deficient embryos.
Regulation of pancreas development by Bmp activity is
mediated through retinoic acid signaling
To study the interaction between Bmp and RA signals, we
performed epistatic studies by adding agonists and antagonists
Fig. 8. Modulation of pancreas development by Bmp signal is mediated through
RA pathway. Both agonists and antagonists of the RA and Bmp pathways were
applied to the same embryo to study the interaction between these two pathways.
Insulin in situ hybridization was performed to analyze endocrine pancreas
development. (A) Control embryo. (B) Embryo injected with 1 ng of chordin
morpholino exhibited expanded domain of insulin expression. (C) DEAB
treatment (10−6 M) of wild-type embryo completely abolished insulin
expression. (D) 1 ng of chordin morpholino injection was notable to restore
insulin expression in embryo treated with DEAB (10−6 M). Scale bar: 50 μm.
(E–H) Complementary experiment: (E) Control embryo treated with RA
(10−6 M) showed expansion of insulin expression domain along the A–P axis.
(F) Embryo injected with 1 ng of alk8 morpholino. (G, H) Two examples of
embryos injected with 1 ng of alk8morpholino followed by treatment of 10−6 M
RA at 9 hpf for 1 h. All samples are dorsal view with anterior to the left. Scale
bar: 50 μm.
Fig. 9. Fgf signals act upstream of RA pathway in pancreas development. In-
sulin in situ hybridization in (A) control embryo injected with water. (B) Embryo
injected with 100 pg of fgf3/8 mRNA. (C). Wild-type embryo treated with
10−6 M of DEAB. (D) Embryo injected with 100 pg of fgf3/8mRNA at one-cell
stage followed by 10−6 M of DEAB treatment. (E–F) Complementary
experiment of embryos treated with RA: (E) wild-type embryo treated with
10−6 M of RA. (F) Embryo injected with 2 ng of fgf3/8morpholino. (G, H) Two
examples of embryos injected with 2 ng of fgf3/8morpholino at one- to two-cell
stages followed by treatment with 10−6 M of RA at 9 hpf. All samples are dorsal
view with anterior to the left. Scale bar: 50 μm.
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activity, chordin morpholino was injected into embryos at the
one-cell stage. At 24 hpf, the resulting embryos exhibited
increased levels of insulin expression (Fig. 8B) compared to
control embryos (Fig. 8A). Using insulin:GFP fish, we
quantified insulin-positive cell numbers. Injection of chordin
morpholino resulted in about 17% increase of insulin cell
number (22.68±2.29 cells per embryo, N=59, Table S3)
compared to control. We also observed that injection of chordin
morpholino resulted in the increase of GFP-positive cells at very
early stage of β cell specification (Fig. 2N). This result suggests
that Bmp activity is sufficient for β cell specification. In
contrast, insulin expression was completely abolished in
embryo treated with 10−5 M of DEAB from 9 hpf onward
(Fig. 8C). Similar absence of insulin expression is observed in
embryos injected with chordin morpholino at one-cell stage
followed by 10−5 M of DEAB treatment from 9 hpf onward
(Fig. 8D). This result implies that RA is required for Bmp
activity to direct β cell development.In the complimentary experiments, we analyzed insulin
expression in embryos treated with RA in different genetic
background. Wild-type embryos were treated with 10−6 M RA
at 9 hpf for 1 h then fixed at 24 hpf for insulin in situ
hybridization. The resulting embryos showed expanded insulin
expression toward the anterior (Fig. 8E). In these embryos,
insulin cell number is 41.49±4.15 per embryo (N=65, Table
S3). Embryos injected with alk8 morpholino exhibited
remarkably reduced insulin expression (Fig. 8F). The cell
number is reduced about 70% (5.46±1.99 cells per embryo,
N=86, Table S3). However, RA treatment following injection
of alk8 morpholino restored insulin expression (Figs. 8G, H) to
a level comparable to control embryos (Fig. 8A). In these
embryos, insulin cell number was restored to about 72% of
control level (13.92±1.74 cells per embryo, N=68). This result
suggests that RA acts genetically downstream of Bmp signal to
direct pancreas development.
RA mediates Fgf signaling in regulating pancreas development
An epistatic study was performed to investigate the
interaction between Fgf and RA signaling pathways. We first
injected fgf3 and fgf8 mRNA together into one-cell stage
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expansion of insulin expression (Fig. 9B) compared with
control (Fig. 9A). The insulin cell number was increased to
20.18±1.39 cells per embryo (N=64, Table S4). However,
treatment with 10−5 M of DEAB following injection of fgf
mRNA completely abolished insulin expression at 24 hpf (Fig.
9D, N=127), similar to DEAB treatment of wild-type embryos
(Fig. 9C, N=102). This result implies that RA is necessary for
Fgf function in regulating endocrine pancreas development.
In the complementary experiments, we injected fgf3 and fgf8
morpholinos together into one-cell stage embryos followed by
RA treatment at 9 hpf for 1 h. Injection of fgf3 and fgf8
morpholinos severely reduced insulin expression (Fig. 9F).
However, RA treatment successfully restored insulin expression
in embryos with an Fgf-deficiency caused by morpholino
injection (Figs. 9G, H), to a level comparable to the control
embryos (Fig. 9A). In these embryos, insulin cell number was
restored to about 81% of the control level (15.92±2.05 cells per
embryo, N=73, Table S4).
This study places Fgf signals genetically upstream of RA
pathway. To support this conclusion, in situ hybridization of
fgf3 and fgf8 was performed in DEAB-treated embryos. Both
fgf3 and fgf8 expressions appear normal in these RA-deficient
embryos (data not shown). The pharyngeal expression of fgf3 isFig. 10. Bmp and Fgf signals genetically interact in β cell development. (A–F) In situ
fgf3/8 and 1 ng of alk8 morpholino-injected embryo, (C) 3 ng of fgf3/8 and 1 ng
embryo, (E) 100 pg of fgf3/8 mRNA and 1 ng of alk8morpholino-injected embryo, (F
bar: 50 μM. (G) Quantification of panels (A–C). insulin-expressing cell number is s
Column 3, alk8 morphant. Column 4, fgf3/8 and alk8 double morphant. Column
Quantification of panels (D–F). insulin-expressing cell number is shown by percen
injected embryo. Column 3, alk8 morphant. Column 4, fgf3/8 mRNA and alk8 morp
and chordin morpholino-injected embryo.significantly reduced as expected. These data suggest that RA is
not required for proper expression of fgf3 and fgf8 in nervous
system and tailbud. Loss of fgf3 expression in pharyngeal
domain is possibly a secondary defect since RA-deficient
causes defects in endodermal patterning.
FGF and Bmp signals interact genetically in β cell
development
An epistatic study was performed to investigate the
interaction between Fgf and Bmp signaling pathways. When
fgf3/8 morpholinos or alk8 morpholino was injected separately
into wild-type embryos, the insulin cell number was reduced to
21.30% and 25.45% respectively (Table S5). Interestingly, in-
sulin cell number was further reduced slightly by about 6%
when fgf3/8 morpholino and alk8 morpholino were injected
together into wild-type embryo (Fig. 10B, Table S5). Con-
versely, insulin cell number was increased mildly by about 5%
when chordin morpholino injection into fgf3/8 morphant
enhanced Bmp activity (Fig. 10C, Table S5).
In the complementary experiments, we first injected fgf3 and
fgf8 mRNA together into one-cell stage embryos. The resulting
embryos exhibited a mild increase and expansion of insulin
expression (Fig. 10D) compared with control (Fig. 10A). Thehybridization using an insulin probe at 24 hpf. (A) Control embryo, (B) 3 ng of
of chordin morpholino-injected embryo, (D) 100 pg of fgf3/8 mRNA-injected
) 100 pg of fgf3/8 mRNA and 1 ng of chordinmorpholino-injected embryo. Scale
hown by percentage to control. Column 1, control. Column 2, fgf3/8 morphant.
5, chordin morphant. Column 6, fgf3/8 and chordin double morphant. (H)
tage to control (Y-axis). Column 1, Control embryo. Column 2, fgf3/8 mRNA-
holino-injected embryo. Column 5, chordin morphant. Column 6, fgf3/8 mRNA
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embryo (N=59, Table S5). Injection of alk8 morpholino into
wild-type embryos caused severe reduction of β cell number
(30.31% of control level, Table S5). It appears that injection of
fgf3/8 mRNA into alk8 morphant can increase insulin cell
number mildly (Fig. 10E, Table S5). This result suggests that
FGF signals possibly function at least partially downstream of
Bmp pathway. On the other hand, overexpression of fgf3/8 and
enhancement of Bmp activity seem to slightly increase insulin
cell number (Fig. 10F, Table S5). Taken together, our results
suggest that Fgf and Bmp interact genetically in β cell
development. It seems that Bmp pathway acts partially
upstream of Fgf signals. One possibility is that Bmp activity
acts at global level to establish anteroposterior axis of the
developing endoderm, whereas Fgf signals are possibly
required for pancreatic cells proliferation. The nature of genetic
interaction between these two pathways remains elusive.
Fgf and RA signals are required for proper vhnf1 expression in
the pancreatic endoderm
Bmp activity is important for vhnf1 expression in the
developing pancreatic area (Fig. 1). Both Fgf and RA signals
are required for proper β cell development. We analyzed
whether Fgf and RA signals are also required for vhnf1
expression in the pancreatic area. In situ hybridization using a
vhnf1 probe was performed for embryos injected with either
fgf3/8 mRNA or fgf3/8 morpholino. No detectable change of
vhnf1 expression was found in embryos injected with fgf3/
8 mRNA (data not shown). This is expected since only slight
change of insulin expression was observed in fgf3/8 mRNA-
injected embryos. However, it appears that endoderm expres-
sion of vhnf1 at 24 hpf is significantly reduced in fgf3/
8 morpholino-injected embryos (Fig. 11B). In addition,
pronephric duct expression of vhnf1 is slightly reduced. This
result indicates that Fgf signals are important for appropriate
expression of vhnf1 in the developing pancreatic area.Fig. 11. Both Fgf and RA signals are required for proper vhnf1 expression in
the developing pancreatic area. (A–D) In situ hybridization using a vhnf1
probe and an insulin probe. (A) Wild-type embryo at 24 hpf. Note the overlap
of insulin and vhnf1 expression in β cell (white arrow). (B) fgf3/8 morphant
(3 ng). Note the significant reduction of vhnf1 or insulin expression in the
pancreatic area (arrowhead). (C) 10−6 M of DEAB-treated wild-type embryo.
No vhnf1 or insulin expression in the pancreatic area (arrowhead). (D) 10−6 M
of RA-treated wild-type embryo. Note expanded expression of insulin and
vhnf1 (arrow).Blockage of RA signal by treatment with 10−5 M of DEAB
completely abolished endodermal expression of vhnf1 in the gut
(Fig. 11C). In contrast, RA treatment of wild-type embryo
caused anterior expansion of vhnf1 in the gut area (Fig. 11D).
Interestingly, the anterior expansion of vhnf1 in RA-treated
embryo is correlated with the expansion of insulin-expressing
cells as shown by double staining (Fig. 11D, vhnf1: purple,
insulin: red). This result further confirmed that RA signal acts
through vhnf1 in β cell development.
Discussion
Although it has been previously shown that Bmp signaling is
required for normal pancreatic development (Tiso et al., 2002),
the molecular mechanism of this regulation is not fully
understood. We report that Bmp activity regulates pancreas
development through the Vhnf1 pathway.
We have demonstrated that Fgf signals are required for
normal zebrafish pancreas development. Inhibition of Fgf
signals by morpholino injection results in dramatic reduction
of insulin-producing cell number. This result is in agreement
with the role that Fgfs play in mammalian pancreas develop-
ment. In addition, we discovered that Fgf signals are also
required for pancreas left–right axis positioning in zebrafish. At
24 hpf, about 40% of embryos injected with fgf3/8 morpholinos
exhibited insulin cells at left side instead of right side in the wild
type. Similarly, the left–right positioning defect is also
described in late stage embryos (72 hpf) in Bmp pathway in
zebrafish (Tiso et al., 2002).
We have further shown that Vhnf1 mediates Fgf signaling in
pancreas development. Injection of vhnf1 mRNA into embryos
injected with fgf3 and fgf8 morpholinos successfully restored
insulin expression to the level comparable to that observed in
wild-type embryos (Figs. 4D–F). An alternative explanation is
that we only generated partial loss of function using the fgf3/
8 morpholinos. Conversely, injection of vhnf1 mRNA in fgf3/
8morphants resulted in over 70% of embryos expressing insulin
at the level comparable to control. In addition, we determined
the timing of Vhnf1 action in response to Fgf signaling. Similar
to the case of Bmp pathway, we found that Vhnf1 also acts at
very early stage of β cell specification. This result indicates that
Vhnf1 functions downstream of Fgf signaling to regulate
pancreas development.
Vhnf1 mutants exhibit severe reduction of insulin expres-
sion (Sun and Hopkins, 2001) as well as complete absence of
insulin expression in some cases (data not shown). This
phenotype is very similar to that observed in embryos treated
with a chemical that blocks the retinoic acid signaling pathway.
It has been shown that Vhnf1 directs posterior hindbrain
development in zebrafish in response to retinoic acid signaling
(Hernandez et al., 2004). Here, we demonstrate that Vhnf1 also
acts downstream of RA in regulating endocrine pancreas
development. RA treatment of wild-type embryos causes
expansion of insulin expression along the anteroposterior axis
(Figs. 6C, 8E, 9E)). One possibility of the reduction to
complete loss of insulin cells in vhnf1 mutants might be that
loss of Vhnf1 activity anteriorizes early endoderm thus
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we expect RA treatment rescues loss of insulin cells in vhnf1
mutants because RA treatment posterizes the remaining
endoderm and causes expansion of pancreatic primordium.
However, RA treatment of vhnf1 mutants does not cause
similar expansion; instead, the insulin expression is similar to
that in vhnf1 mutants (Fig. 6D). This result indicates that
Vhnf1 is required for RA signaling in directing pancreas
development. Reciprocally, injection of vhnf1 mRNA can
overcome the defects in pancreas development caused by
blocking RA signal with DEAB (Figs. 7D, E). Thus, our data
suggest that Vhnf1 is both necessary and sufficient for RA
action in directing pancreas development.
Retinoic acid (RA) has conserved roles in pattern formation
and organogenesis during vertebrate development. RA signals
through retinoic acid receptors (RARs). RARs interact with co-
repressors when RA is not available. Upon RA binding, the co-
repressors are replaced by co-activators which in turn lead to
transcriptional activation (Germain et al., 2002). Three zebra-
fish RAR genes have been previously reported (Begemann et
al., 2001; Joore et al., 1994; Stafford and Prince, 2002).
Recently, it has been reported that RA signal depends on RARs
to instruct pancreas development (Stafford et al., 2006). In
zebrafish vhnf1 gene, two potential Direct Repeat 1 (DR1)-like
binding sites for RAR are present (data not shown). This
suggests that vhnf1 gene could potentially regulate RA
signaling directly through RAR binding.Fig. 12. (A) Double in situ hybridization using a vhnf1 probe and an insulin probe. vh
integration of signals of Bmp, Fgf, and RA in pancreas development. Progenitor cells
to turn on vhnf1 expression. Vhnf1 in sequence turns other gene expressions in the
genetically upstream of RA. Fgf signals act at least partially downstream of Bmp pat
Fgf signals to the progenitor cells. Thus, vhnf1 serves as an integration factor of theA model of Vhnf1 integrates Fgf, Bmp, and RA signaling
pathways to regulate pancreas development
Vhnf1 is expressed dynamically during zebrafish embryo-
genesis (Gong et al., 2004; Sun and Hopkins, 2001). To further
demonstrate the relationship of vhnf1 and insulin expression in
the developing zebrafish embryo, we performed double in situ
hybridization of these two genes (Fig. 12A). vhnf1 expression is
weakly detectable in the developing pancreatic area at 12-
somite stage when only a few cells start to express insulin. As
the embryo develops, endodermal expression of vhnf1 becomes
more obvious in the gut area and the level of expression
enhances at 14-somite and 18-somite stages. The highest level
of vhnf1 expression is reached at 24 hpf in the pancreatic area.
Interestingly, the increase of insulin expression is correlated
with the increase of vhnf1 expression.
Based on the observations described in this study, a model
for the mechanism of pancreas development from the
endodermal signaling to endocrine cell specification is proposed
(Fig. 12B). The transcription factor Vhnf1 responses to signals
of Bmp, Fgf and RA during pancreas development. Therefore,
Vhnf1 serves as a common target for different signals involved
in the process of pancreas development. However, both Bmp
and Fgf signals may also have Vhnf1-independent roles in β
cell development since vhnf1 mRNA failed to completely
rescue insulin cell numbers in Bmp or Fgf defect embryos. This
model demonstrates that pancreatic precursor cells respond tonf1: purple. insulin: red. Stages of embryo are as labeled. (B) A model for vhnf1
in the developing pancreatic primordium respond to signals of Bmp, Fgf, and RA
se cells that eventually differentiate into β cells. Both Bmp and Fgf signals act
hway. Gray arrows indicate possible Vhnf1-independent pathways from Bmp or
extrinsic signals that instruct endocrine pancreas development.
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on the transcription program that directs and drives the cells to
develop into pancreatic cells.
These signals that Vhnf1 integrates represent intercellular
interactions during pancreas development. The dorsoventral
Bmp signal is involved in endoderm precursor pre-patterning.
Fate map experiment showed that the endodermal precursors are
pre-patterned in a fashion closely related to dorsoventral axis.
The anterior structures originate from the endodermal precursors
located more dorsally, whereas the posterior structures derive
from those situated ventrolateral (Warga and Nusslein-Volhard,
1999). Therefore, Bmp signal appears to be giving instruction to
the position of pancreas along the anteroposterior axis. Using
cell transplantations, Stafford et al. have recently showed that
RA signal derived from the anterior paraxial mesoderm adjacent
to endoderm is instructive to both specification of pancreas and
localization in anteroposterior axis (Stafford et al., 2006). There
are two different intercellular interactions involving Fgf signals.
In chicken, Fgf2 secreted from the notochord is required to
repress SHH expression at the prepancreatic dorsal endoderm in
order to permit pancreas development (Hebrok et al., 1998). On
the other hand, Fgf10 is important for the mesenchymal-to-
epithelial interaction during pancreas development (Norgaard et
al., 2003). A different role of SHH during zebrafish pancreas
development has been described. Overexpression of SHH in
zebrafish embryos resulted in ectopic induction of endodermal
pdx-1 expression and supernumerary differentiated endocrine
cells. On the other hand, disruption of SHH signaling leads to
reduction of pdx-1 expression and almost complete absence of
the endocrine pancreas (Roy et al., 2001). At present, which type
of intercellular interactions for Fgf signals during zebrafish
pancreas development remains elusive. To understand the
mechanism of intercellular interactions for Fgf signals, it is
critical to determine the source of Fgf signals for Zebrafish
pancreas development. Both fgf3 and fgf8 genes are expressed
during early development in Zebrafish (Furthauer et al., 1997;
Kiefer et al., 1996; Raible and Brand, 2001; Reifers et al., 1998).
Previous study in zebrafish showed that Fgf8 cooperates with
Chordin to establish appropriate DV patterning (Furthauer et al.,
2004). It is possible that Fgf signals regulate pancreas
development by ensure appropriate DV patterning in coopera-
tion with Chordin. However, this cannot explain why β cell is
dramatically reduced in fgf morpholino-injected embryos.
Therefore, Fgf signals have other roles in β cell development.
MHB and presomitic mesoderm are two potential sources for
Fgf signaling. During the onset of β cell specification, the
earliest emerged β cells are closer to MHB area than it appears
later. The differentiated β cells migrate posteriorly during
embryogenesis and form one cluster along the midline at the
somatic area at 24 hpf. The presomitic area is another potential
source.
We have shown that these different signals interact with each
other at the level above the integration site. Epistatic studies
indicate that Bmp signals act upstream of RA to activate vhnf1
expression during pancreas development. Epistatic study also
revealed the interaction between Fgf signals and the RA
pathway. Injection of fgf3 and fgf8 mRNAs into wild-typeembryos caused slight expansion of insulin expression (Fig.
9B). On the other hand, disruption of Fgf signaling by
morpholino injection resulted in severe reduction of insulin
expression (Fig. 9F). One possibility is that Fgf signaling
expands committed pancreatic progenitors. If this were true, one
would expect that fgf mRNA could rescue pancreatic defect
when RA pathway is chemically blocked. However, this is not
the case. Our data showed that not only the expansion but also
insulin expression in embryos injected with fgf mRNAs were
completely blocked when treating the embryos with DEAB
(Fig. 9D). Apparently, RA is necessary for Fgf signaling in
pancreas development. When RA treatment was applied to
embryos with an Fgf deficiency caused by morpholino
injection, insulin expression levels were restored (Figs. 9G,
H). These data place RA signaling downstream of Fgf in
pancreas development. Although RA treatment restored insulin
cell number in the fgf morphants to over 70% of control level, it
is still only one third compared to the level in RA-treated wild-
type embryos. Thus, our result does not rule out the possibility
that Fgf signals function as survival factors for pancreatic
progenitors.
In summary, we show in the present paper that Vhnf1
responds to different signals, from different sources of cell
interactions. Vhnf1 is required for dorsoventral Bmp signaling
to regulate pancreas development. Fgf function in pancreas
development is also mediated through Vhnf1 pathway. RA is
essential for pancreas development and it also signals through
Vhnf1 pathway. Therefore, Vhnf1 integrates these intercellular
signals to promote pancreas development. This study also
provides direct evidence that a combination of signals act in a
concert to regulate pancreas development.
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